These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33023818)

  • 1. A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus.
    Muirhead R; Bulte D; Cooke R; Chu KY; Durrant L; Goh V; Jacobs C; Ng SM; Strauss VY; Virdee PS; Qi C; Hawkins MA
    Clin Oncol (R Coll Radiol); 2020 Dec; 32(12):874-883. PubMed ID: 33023818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy and Clinical Impact of Persistent Disease Diagnosed on Diffusion-Weighted Imaging and Accuracy of Pelvic Nodal Assessment on Magnetic Resonance Imaging for Squamous Cell Carcinoma of the Anus in the 6-Month Interval Post Chemoradiotherapy.
    Fernandes MC; Charbel C; Romesser PB; Ucpinar BA; Homsi ME; Yildirim O; Fuqua JL; Rodriguez LA; Zheng J; Capanu M; Gollub MJ; Horvat N
    Int J Radiat Oncol Biol Phys; 2024 Sep; 120(1):120-129. PubMed ID: 38462017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma.
    Prezzi D; Muthuswamy K; Amlani A; Owczarczyk K; Elowaidy A; Mistry T; Bassett P; Goh V
    Eur Radiol; 2023 Nov; 33(11):7575-7584. PubMed ID: 37462820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer.
    Kochhar R; Renehan AG; Mullan D; Chakrabarty B; Saunders MP; Carrington BM
    Eur Radiol; 2017 Feb; 27(2):607-617. PubMed ID: 27090113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.
    Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N
    Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer.
    Owczarczyk K; Prezzi D; Cascino M; Kozarski R; Gaya A; Siddique M; Cook GJ; Glynne-Jones R; Goh V
    Radiother Oncol; 2019 May; 134():119-126. PubMed ID: 31005205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
    Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
    Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival?
    Severino NP; Chadi SA; Rosen L; Coiro S; Choman E; Berho M; Wexner SD
    Colorectal Dis; 2016 Oct; 18(10):959-966. PubMed ID: 26850085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers.
    Tshering Vogel DW; Zbaeren P; Geretschlaeger A; Vermathen P; De Keyzer F; Thoeny HC
    Eur Radiol; 2013 Feb; 23(2):562-9. PubMed ID: 22865270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.
    Hocquelet A; Auriac T; Perier C; Dromain C; Meyer M; Pinaquy JB; Denys A; Trillaud H; Denis De Senneville B; Vendrely V
    Eur Radiol; 2018 Jul; 28(7):2801-2811. PubMed ID: 29404766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
    Onal C; Erbay G; Guler OC
    J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
    Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z
    Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy.
    Kozumi M; Ota H; Yamamoto T; Umezawa R; Matsushita H; Ishikawa Y; Takahashi N; Matsuura T; Takase K; Jingu K
    Eur Radiol; 2018 Oct; 28(10):4296-4305. PubMed ID: 29725833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
    Gu KW; Kim CK; Choi CH; Yoon YC; Park W
    Eur Radiol; 2019 Nov; 29(11):6236-6244. PubMed ID: 30980126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
    Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
    J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
    Zhao B; Cao K; Li XT; Zhu HT; Sun YS
    BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
    Makino H; Kato H; Furui T; Morishige K; Kanematsu M
    J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial.
    Jones MP; Hruby G; Metser U; Sridharan S; Capp A; Kumar M; Gallagher S; Rutherford N; Holder C; Oldmeadow C; Martin J
    Radiat Oncol; 2019 Aug; 14(1):140. PubMed ID: 31387597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.